Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Spero Therapeutics, Inc. (SPRO)
USD1.69
-0.02 (-0.88%)
US NASDAQ Healthcare Biotechnology
Address
675 Massachusetts Avenue 2139
Cambridge, MA, US
Cambridge, MA, US
CEO
Esther Rajavelu
Website
sperotherapeutics.com
IPO
2017-11-02
CIK 1701108 ISIN US84833T1034
Description
Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic designed to address complicated urinary tract infections (cUTIs), including pyelonephritis, in adult patients. SPR206, an intravenously administered agent specifically developed to combat MDR Gram-negative bacterial infections in hospital environments. SPR720, an oral antibiotic targeting non-tuberculous mycobacterial (NTM) pulmonary disease. Spero Therapeutics has also forged several strategic alliances: A licensing agreement with Meiji Seika Pharma Co., Ltd. supports the ongoing development of tebipenem HBr. A separate licensing deal with Everest Medicines grants rights for the development, manufacturing, and commercialization of SPR206 across Greater China, South Korea, and various Southeast Asian nations. The company collaborates with the Bill & Melinda Gates Medical Research Institute to advance SPR720 for treating lung infections caused by Mycobacterium tuberculosis. Furthermore, a licensing agreement with Vertex Pharmaceuticals Incorporated covers patents associated with SPR720 and its active metabolite, SPR719. Founded in 2013, Spero Therapeutics maintains its corporate headquarters in Cambridge, Massachusetts.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.69
-0.02 (-0.88%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.49
Float Shares
47.33M
Free Float %
81.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.39% | +0.00% | -4.87% | +6.72% | -4.51% | +9.01% | +316.39% | +37.30% | -80.11% | -77.91% | -77.91% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (13 ratings, all time)
Buy
Price Targets & DCF
Current price
1.69
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.98
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+24.3% ★ Q1'26: -95.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+111.8% ★ Q1'26: +48.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-0.5% Q1'26: +6,148.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%0.0% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-0.1% ★
-
Share dilution Biotechnology: -3.4%+9.3% Q1'26: +3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-120.63× Q1'26: -0.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.98M
est: 1.45M (+36.3%)
|
3.97M
est: 3.02M (+31.4%)
|
18.15M
est: 18.22M (-0.4%)
|
9.33M
est: 11.07M (-15.7%)
|
3.07M
est: 19.96M (-84.6%)
|
48.58M
est: 7.12M (+582.0%)
|
103.78M
est: 118.46M (-12.4%)
|
47.98M
est: 38.97M (+23.1%)
|
59.62M
est: 25.50M (+133.8%)
|
800.0K
800.0K – 800.0K
-96.9% YoY
|
3.20M
3.20M – 3.20M
+300.0% YoY
|
33.10M
33.10M – 33.10M
+934.4% YoY
|
99.10M
99.10M – 99.10M
+199.4% YoY
|
| EBITDA |
-41.37M
est: -1.05M (-3,831.9%)
|
-42.40M
est: -2.19M (-1,838.7%)
|
-62.47M
est: -13.20M (-373.2%)
|
-78.35M
est: -8.02M (-876.9%)
|
-87.17M
est: -14.46M (-502.8%)
|
-42.94M
est: -5.16M (-732.2%)
|
27.15M
est: -62.14M (+143.7%)
|
-72.48M
est: -20.44M (-254.6%)
|
-24.0K
est: -13.38M (+99.8%)
|
-419.6K
-419.6K – -419.6K
+96.9% YoY
|
-1.68M
-1.68M – -1.68M
-300.0% YoY
|
-17.36M
-17.36M – -17.36M
-934.4% YoY
|
-51.98M
-51.98M – -51.98M
-199.4% YoY
|
| EBIT |
-41.73M
est: -1.06M (-3,843.0%)
|
-42.81M
est: -2.20M (-1,845.9%)
|
-63.22M
est: -13.28M (-376.1%)
|
-79.11M
est: -8.07M (-880.6%)
|
-87.82M
est: -14.55M (-503.7%)
|
-43.81M
est: -5.19M (-744.0%)
|
26.79M
est: -62.64M (+142.8%)
|
-72.48M
est: -20.61M (-251.8%)
|
-24.0K
est: -13.49M (+99.8%)
|
-423.1K
-423.1K – -423.1K
+96.9% YoY
|
-1.69M
-1.69M – -1.69M
-300.0% YoY
|
-17.50M
-17.50M – -17.50M
-934.4% YoY
|
-52.41M
-52.41M – -52.41M
-199.4% YoY
|
| Net Income |
-46.10M
est: -676.69M (+93.2%)
|
-41.66M
est: -148.50M (+71.9%)
|
-60.93M
est: -167.75M (+63.7%)
|
-78.28M
est: -187.36M (+58.2%)
|
-89.76M
est: -147.25M (+39.0%)
|
-46.42M
est: -106.45M (+56.4%)
|
22.81M
est: 19.33M (+18.0%)
|
-68.57M
est: -53.60M (-27.9%)
|
8.57M
est: -5.90M (+245.2%)
|
39.56M
39.56M – 39.56M
+770.0% YoY
|
-40.15M
-40.15M – -40.15M
-201.5% YoY
|
-7.08M
-7.08M – -7.08M
+82.4% YoY
|
44.28M
44.28M – 44.28M
+725.0% YoY
|
| SGA |
10.84M
est: 5.05M (+114.8%)
|
12.89M
est: 10.49M (+22.9%)
|
15.59M
est: 63.31M (-75.4%)
|
21.44M
est: 38.47M (-44.3%)
|
41.70M
est: 69.36M (-39.9%)
|
36.48M
est: 24.75M (+47.4%)
|
25.55M
est: 365.56M (-93.0%)
|
23.70M
est: 120.25M (-80.3%)
|
21.18M
est: 78.69M (-73.1%)
|
2.47M
2.47M – 2.47M
-96.9% YoY
|
9.88M
9.88M – 9.88M
+300.0% YoY
|
102.15M
102.15M – 102.15M
+934.4% YoY
|
305.82M
305.82M – 305.82M
+199.4% YoY
|
| EPS |
-17.82
est: -12.52 (-42.3%)
|
-2.60
est: -2.75 (+5.4%)
|
-3.31
est: -3.10 (-6.6%)
|
-3.52
est: -3.47 (-1.5%)
|
-2.91
est: -2.73 (-6.8%)
|
-1.23
est: -1.97 (+37.6%)
|
0.43
est: 0.33 (+31.3%)
|
-1.27
est: -0.92 (-38.0%)
|
0.15
est: -0.10 (+250.0%)
|
0.67
0.67 – 0.67
+770.0% YoY
|
-0.68
-0.68 – -0.68
-201.5% YoY
|
-0.12
-0.12 – -0.12
+82.4% YoY
|
0.75
0.75 – 0.75
+725.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.36M
OE per share TTM
-0.18
Owner's Yield
-7.28%
Maintenance CapEx ratio
10.14%
Maint CapEx / Avg PPE
13.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
2.41M
Insider transactions (90d)
1
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GSK plc | 9.19M | 19.99% | 9.19M | — | 9.19M | — | CO | England and Wales | 2022-11-14 | ↗ |
| 2 | Amin Nathoo | 4.30M | 8.10% | — | 4.30M | — | 4.30M | HC, IN | Texas | 2024-02-14 | ↗ |
| 3 | Anson Advisors Inc. | 4.30M | 8.10% | — | 4.30M | — | 4.30M | FI, CO | Texas | 2024-02-14 | ↗ |
| 4 | Anson Funds Management LP | 4.30M | 8.10% | — | 4.30M | — | 4.30M | IA, PN | Texas | 2024-02-14 | ↗ |
| 5 | Anson Management GP LLC | 4.30M | 8.10% | — | 4.30M | — | 4.30M | HC, OO | Texas | 2024-02-14 | ↗ |
| 6 | Moez Kassam | 4.30M | 8.10% | — | 4.30M | — | 4.30M | HC, IN | Texas | 2024-02-14 | ↗ |
| 7 | Tony Moore | 4.30M | 8.10% | — | 4.30M | — | 4.30M | HC, IN | Texas | 2024-02-14 | ↗ |
| 8 | Aquilo Capital Management, LLC | 3.42M | 9.80% | — | 3.42M | — | — | IA, HC, OO | Delaware | 2022-10-03 | ↗ |
| 9 | Marc Schneidman | 3.42M | 9.80% | — | 3.42M | — | — | HC, IN | Delaware | 2022-10-03 | ↗ |
| 10 | PFIZER INC. | 2.36M | 7.37% | 2.36M | — | 2.36M | — | CO | Delaware | 2021-07-09 | ↗ |
| 11 | Aquilo Capital, L.P. | 2.18M | 6.20% | — | 2.18M | — | — | PN | Delaware | 2022-10-03 | ↗ |
| 12 | Atlas Venture Associates IX, L.P. | 1.38M | 5.06% | — | 1.38M | — | — | PN | Delaware | 2021-02-02 | ↗ |
| 13 | Atlas Venture Fund IX, L.P. | 1.38M | 5.06% | — | 1.38M | — | — | PN | Delaware | 2021-02-02 | ↗ |
| 14 | Atlas Venture Associates IX, Inc. | 1.38M | 4.26% | — | 1.38M | — | 1.38M | OO | Delaware | 2022-01-25 | ↗ |
| 15 | Aquilo Capital LO, L.P. | 1.24M | 3.60% | — | 1.24M | — | — | PN | Delaware | 2022-10-03 | ↗ |
| 16 | ATLAS VENTURE ASSOCIATES X, L.P. | 1.03M | 3.80% | — | 1.03M | — | 10.00 | PN | — | 2021-02-16 | ↗ |
| 17 | ATLAS VENTURE FUND X, L.P. | 1.03M | 3.80% | — | 1.03M | — | 10.00 | PN | — | 2021-02-16 | ↗ |
| 18 | Alphabet Holdings LLC | 890.0K | 3.27% | 890.0K | — | 890.0K | — | OO | — | 2021-02-10 | ↗ |
| 19 | Alphabet Inc. | 890.0K | 3.27% | 890.0K | — | 890.0K | — | HC, CO | — | 2021-02-10 | ↗ |
| 20 | GV 2015 GP, L.L.C. | 890.0K | 3.27% | 890.0K | — | 890.0K | — | OO | — | 2021-02-10 | ↗ |
| 21 | GV 2015, L.P. | 890.0K | 3.27% | 890.0K | — | 890.0K | — | PN | — | 2021-02-10 | ↗ |
| 22 | XXVI Holdings Inc. | 890.0K | 3.27% | 890.0K | — | 890.0K | — | CO | — | 2021-02-10 | ↗ |
| 23 | (1) BlackRock, Inc. | 690.8K | 2.10% | 690.3K | — | 690.8K | — | HC | Delaware | 2022-07-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-48 vs prev Q
New positions
0
Closed positions
46
Increased
0
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GSK PLC | 9.19M +9.2M (+100.0%) | 21.41M +21.4M (+100.0%) | 16.33% +16.330 pp | 2.68% +2.680 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 2 | PFIZER INC | 2.36M +— (+0.0%) | 5.50M +1.1M (+23.9%) | 4.20% -0.019 pp | 2.33% +1.313 pp | USD1.03 +126.2% | 5 qtrs — |
| 3 | VANGUARD GROUP INC | 2.08M +93.6K (+4.7%) | 4.85M +1.1M (+29.8%) | 3.70% +0.150 pp | 0.00% +0.000 pp | USD7.55 -69.1% | 33 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 1.28M -173.2K (-11.9%) | 2.98M +250.1K (+9.2%) | 2.27% -0.320 pp | 0.00% +0.001 pp | USD1.69 +37.9% | 16 qtrs — |
| 5 | ALPHABET INC. | 890.0K +— (+0.0%) | 2.07M +400.5K (+23.9%) | 1.58% -0.007 pp | 0.08% +0.011 pp | USD11.75 -80.2% | 33 qtrs — |
| 6 | ANSON FUNDS MANAGEMENT LP | 625.1K -978.5K (-61.0%) | 1.46M -1.6M (-51.7%) | 1.11% -1.752 pp | 0.14% -0.136 pp | USD1.68 +38.7% | 14 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 529.2K +1.7K (+0.3%) | 1.23M +241.4K (+24.3%) | 0.94% -0.001 pp | 0.00% +0.000 pp | USD7.74 -69.9% | 32 qtrs — |
| 8 | BLACKROCK, INC. | 433.6K -1.2K (-0.3%) | 1.01M +193.0K (+23.6%) | 0.77% -0.006 pp | 0.00% +0.000 pp | USD1.34 +73.9% | 6 qtrs — |
| 9 | TWO SIGMA INVESTMENTS, LP | 372.6K +323.2K (+654.2%) | 868.1K +775.2K (+834.7%) | 0.66% +0.574 pp | 0.00% +0.001 pp | USD2.27 +2.6% | 2 qtrs — |
| 10 | EAM INVESTORS, LLC | 218.1K -64.4K (-22.8%) | 508.1K -22.9K (-4.3%) | 0.39% -0.117 pp | 0.06% -0.004 pp | USD2.74 -15.0% | 3 qtrs — |
| 11 | TWO SIGMA ADVISERS, LP | 216.6K +216.6K (+100.0%) | 504.7K +504.7K (+100.0%) | 0.38% +0.385 pp | 0.00% +0.001 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 12 | STATE STREET CORP | 210.2K +19.2K (+10.1%) | 489.7K +130.7K (+36.4%) | 0.37% +0.033 pp | 0.00% +0.000 pp | USD7.12 -67.3% | 32 qtrs — |
| 13 | IONIC CAPITAL MANAGEMENT LLC | 195.9K -12.8K (-6.1%) | 456.5K +64.1K (+16.3%) | 0.35% -0.024 pp | 0.06% +0.017 pp | USD2.61 -10.7% | 3 qtrs — |
| 14 | GSA CAPITAL PARTNERS LLP | 178.9K +72.0K (+67.4%) | 417.0K +216.0K (+107.5%) | 0.32% +0.127 pp | 0.04% +0.019 pp | USD2.06 +13.1% | 2 qtrs — |
| 15 | INTREPID FAMILY OFFICE LLC | 165.0K +55.0K (+50.0%) | 384.5K +177.7K (+85.9%) | 0.29% +0.097 pp | 0.33% +0.158 pp | USD2.03 +14.8% | 2 qtrs — |
| 16 | SEI INVESTMENTS CO | 132.0K +132.0K (+100.0%) | 307.6K +307.6K (+100.0%) | 0.23% +0.235 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 17 | OMERS ADMINISTRATION CORP | 131.1K +131.1K (+100.0%) | 305.5K +305.5K (+100.0%) | 0.23% +0.233 pp | 0.00% +0.002 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 18 | NORTHERN TRUST CORP | 121.0K -8.7K (-6.7%) | 281.9K +38.2K (+15.7%) | 0.22% -0.016 pp | 0.00% +0.000 pp | USD6.19 -62.4% | 33 qtrs — |
| 19 | SQUAREPOINT OPS LLC | 119.4K +119.4K (+100.0%) | 278.3K +278.3K (+100.0%) | 0.21% +0.212 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 20 | UBS GROUP AG | 116.4K +89.3K (+329.7%) | 271.3K +220.4K (+432.5%) | 0.21% +0.159 pp | 0.00% +0.000 pp | USD2.24 +4.0% | 33 qtrs — |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 114.8K +— (+0.0%) | 267.5K +51.7K (+23.9%) | 0.20% -0.001 pp | 0.01% +0.001 pp | USD1.51 +54.3% | 12 qtrs — |
| 22 | ADAR1 CAPITAL MANAGEMENT, LLC | 113.8K -1.7K (-1.5%) | 265.2K +48.0K (+22.1%) | 0.20% -0.004 pp | 0.02% -0.001 pp | USD1.44 +61.8% | 9 qtrs — |
| 23 | CITADEL ADVISORS LLC | 73.1K +18.3K (+33.4%) | 170.3K +67.3K (+65.3%) | 0.13% +0.032 pp | 0.00% +0.000 pp | USD2.76 -15.6% | 7 qtrs — |
| 24 | SHAY CAPITAL LLC | 60.3K -3.4K (-5.3%) | 140.5K +20.8K (+17.4%) | 0.11% -0.007 pp | 0.01% +0.004 pp | USD1.88 +23.9% | 2 qtrs — |
| 25 | POINT72 ASSET MANAGEMENT, L.P. | 43.6K +43.6K (+100.0%) | 101.5K +101.5K (+100.0%) | 0.08% +0.077 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 26 | JANE STREET GROUP, LLC | 38.6K +38.6K (+100.0%) | 89.9K +89.9K (+100.0%) | 0.07% +0.069 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 27 | QUADRATURE CAPITAL LTD | 37.8K +37.8K (+100.0%) | 88.1K +88.1K (+100.0%) | 0.07% +0.067 pp | 0.00% +0.001 pp | USD2.33 +0.0% | 3 qtrs — |
| 28 | SIMPLEX TRADING, LLC | 35.7K +28.1K (+368.4%) | 83.1K +69.1K (+493.9%) | 0.06% +0.050 pp | 0.00% +0.000 pp | USD2.39 -2.5% | 6 qtrs — |
| 29 | CAPITAL ASSET ADVISORY SERVICES LLC | 32.5K +— (+0.0%) | 81.7K +20.5K (+33.5%) | 0.06% 0.000 pp | 0.00% +0.001 pp | USD2.90 -19.7% | 3 qtrs — |
| 30 | AXXCESS WEALTH MANAGEMENT, LLC | 32.5K +— (+0.0%) | 75.8K +14.6K (+23.9%) | 0.06% 0.000 pp | 0.00% 0.000 pp | USD2.90 -19.7% | 3 qtrs — |
| 31 | THREE SEASONS WEALTH, LLC | 30.0K +— (+0.0%) | 69.9K +13.5K (+23.9%) | 0.05% 0.000 pp | 0.01% +0.001 pp | USD1.41 +65.2% | 9 qtrs — |
| 32 | DIMENSIONAL FUND ADVISORS LP | 29.8K +774.0 (+2.7%) | 69.0K +14.2K (+25.9%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD1.89 +23.3% | 2 qtrs — |
| 33 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 28.6K +— (+0.0%) | 66.6K +12.9K (+23.9%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD1.73 +34.7% | 13 qtrs — |
| 34 | INVESCO LTD. | 24.7K +2.6K (+11.8%) | 57.6K +16.0K (+38.5%) | 0.04% +0.005 pp | 0.00% +0.000 pp | USD2.55 -8.6% | 3 qtrs — |
| 35 | MILLENNIUM MANAGEMENT LLC | 24.1K +24.1K (+100.0%) | 56.2K +56.2K (+100.0%) | 0.04% +0.043 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 36 | ASSENAGON ASSET MANAGEMENT S.A. | 18.6K -18.4K (-49.6%) | 43.4K -26.1K (-37.6%) | 0.03% -0.033 pp | 0.00% +0.000 pp | USD1.88 +23.9% | 2 qtrs — |
| 37 | — | 17.0K +1.3K (+7.9%) | 39.7K +10.0K (+33.8%) | 0.03% +0.002 pp | 0.01% +0.005 pp | USD1.91 +22.0% | 2 qtrs — |
| 38 | XTX TOPCO LTD | 15.2K -18.6K (-55.1%) | 35.4K -28.2K (-44.4%) | 0.03% -0.033 pp | 0.00% -0.002 pp | USD2.90 -19.7% | 5 qtrs — |
| 39 | TEXAS YALE CAPITAL CORP. | 10.0K +— (+0.0%) | 23.3K +4.5K (+23.9%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD1.03 +126.2% | 13 qtrs — |
| 40 | TOWER RESEARCH CAPITAL LLC (TRC) | 7.2K +7.2K (+100.0%) | 16.8K +16.8K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 23 qtrs — |
| 41 | JONES FINANCIAL COMPANIES LLLP | 6.5K +6.5K (+100.0%) | 15.1K +15.1K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 1 qtrs NEW |
| 42 | JPMORGAN CHASE & CO | 5.4K +5.1K (+2,176.7%) | 12.5K +12.1K (+2,719.6%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD2.27 +2.6% | 11 qtrs — |
| 43 | FNY INVESTMENT ADVISERS, LLC | 5.3K +— (+0.0%) | 12.0K +3.0K (+33.3%) | 0.01% +0.000 pp | 0.00% +0.001 pp | USD1.88 +23.9% | 2 qtrs — |
| 44 | CULLEN/FROST BANKERS, INC. | 3.0K +3.0K (+100.0%) | 7.0K +7.0K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD2.33 +0.0% | 7 qtrs — |
| 45 | BANK OF AMERICA CORP /DE/ | 744.00 +11.0 (+1.5%) | 1.7K +356.0 (+25.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.23 -44.9% | 33 qtrs — |
| 46 | MORGAN STANLEY | 313.00 -43.1K (-99.3%) | 729.00 -80.8K (-99.1%) | 0.00% -0.077 pp | 0.00% +0.000 pp | USD2.45 -4.9% | 33 qtrs — |
| 47 | ADVISOR GROUP HOLDINGS, INC. | 290.00 +— (+0.0%) | 675.00 +130.0 (+23.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.90 -19.7% | 21 qtrs — |
| 48 | WELLS FARGO & COMPANY/MN | 200.00 +— (+0.0%) | 466.00 +90.0 (+23.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.48 +57.4% | 33 qtrs — |
| 49 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 200.00 +— (+0.0%) | 466.00 +90.0 (+23.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.88 +23.9% | 2 qtrs — |
| 50 | US BANCORP \DE\ | 151.00 +— (+0.0%) | 352.00 +68.0 (+23.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.05 +121.9% | 13 qtrs — |
| 51 | BNP PARIBAS ARBITRAGE, SNC | 40.00 +— (+0.0%) | 93.00 +18.0 (+24.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.38 -2.1% | 10 qtrs — |
| 52 | SAGEVIEW ADVISORY GROUP, LLC | 17.00 +17.0 (+100.0%) | 40.00 +40.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.29 +1.7% | 1 qtrs NEW |
| 53 | CITIGROUP INC | 17.00 +17.0 (+100.0%) | 40.00 +40.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.29 +1.7% | 1 qtrs NEW |
| 54 | FARTHER FINANCE ADVISORS, LLC | 10.00 +10.0 (+100.0%) | 23.00 +23.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.30 +1.3% | 1 qtrs NEW |
| 55 | SBI SECURITIES CO., LTD. | 9.00 -1.0 (-10.0%) | 21.00 +2.0 (+10.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +133.0% | 5 qtrs — |
| 56 | AMERICAN CENTURY COMPANIES INC | — -40.2K (-100.0%) | — -75.6K (-100.0%) | 0.00% -0.072 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 57 | GROUP ONE TRADING, L.P. | — -16.9K (-100.0%) | — -31.7K (-100.0%) | 0.00% -0.030 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 58 | RANGELEY CAPITAL, LLC | — -30.0K (-100.0%) | — -56.4K (-100.0%) | 0.00% -0.054 pp | 0.00% -0.049 pp | USD— | 2 qtrs SOLD |
| 59 | NEWEDGE ADVISORS, LLC | — -100.0 (-100.0%) | — -188.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 60 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -10.9K (-100.0%) | — -20.5K (-100.0%) | 0.00% -0.020 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 61 | FMR LLC | — -550.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
| 62 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | — -150.5K (-100.0%) | — -283.0K (-100.0%) | 0.00% -0.269 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 20 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.37% | 81.4K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.02% | 317.5K | 0.60% |
| 3 | Avantis U.S. Small Cap Equity ETF AVSC | 0.00% | 77.3K | 0.25% |
| 4 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.00% | 56.5K | 0.34% |
| 5 | Vanguard Extended Market ETF VXF | 0.00% | 1.42M | 0.05% |
| 6 | U.S. Micro Cap Portfolio ETF DFMC | 0.00% | 101.0K | 0.43% |
| 7 | Dimensional - US Small Cap ETF DFAS | 0.00% | 140.0K | 0.26% |
| 8 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 17.0K | 0.14% |
| 9 | Dimensional - US Targeted Value ETF DFAT | 0.00% | 53.4K | 0.28% |
| 10 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.5K | 0.17% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
4
Sells
4
Shares acquired
952.0K
Shares disposed
65.0K
Cash buys
—
Cash sales
4.00
Net activity
+886,972
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 25,240 | 2.51 | 63.4K | 986,851 | D | ↗ |
| 2026-02-06 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 37,101 | 2.36 | 87.6K | 1,062,907 | D | ↗ |
| 2026-02-06 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 18,652 | 2.36 | 44.0K | 742,506 | D | ↗ |
| 2026-02-04 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 3,471 | 2.24 | 7.8K | 761,158 | D | ↗ |
| 2026-02-03 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 24,224 | 2.14 | 51.8K | 764,629 | D | ↗ |
| 2026-02-02 | Rajavelu Esther | Officer | A-Award | A | Stock Option (Right to Buy) | 498,000 | 2.23 | 1.11M | 498,000 | D | ↗ |
| 2026-02-02 | Keutzer Timothy | Officer | A-Award | A | Stock Option (Right to Buy) | 137,000 | 2.23 | 305.5K | 137,000 | D | ↗ |
| 2025-11-07 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 40,270 | 2.37 | 95.4K | 869,450 | D | ↗ |
| 2025-08-28 | Mahadevia Ankit | Director | S-Sale | D | Common Stock | 6,572 | 1.97 | 12.9K | 703,294 | D | ↗ |
| 2025-08-28 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 1,695 | 1.97 | 3.3K | 739,744 | D | ↗ |
| 2025-06-12 | VINK PATRICK V.J.J. | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | Tregoning Kathleen | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | THOMAS FRANK E | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | Smith Cynthia | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | Pottage John C Jr | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | Mahadevia Ankit | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 709,866 | D | ↗ |
| 2025-06-12 | Jackson Scott Thomas | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 75,000 | D | ↗ |
| 2025-06-12 | Deshpande Milind | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 91,454 | D | ↗ |
| 2025-05-02 | Rajavelu Esther | Officer | A-Award | A | Common Stock | 185,000 | 0.00 | — | 909,720 | D | ↗ |
| 2025-02-05 | Shukla Sath | Officer | S-Sale | D | Common Stock | 106,408 | 0.78 | 83.0K | 1,736,883 | D | ↗ |
| 2025-02-05 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 20,689 | 0.78 | 16.1K | 724,720 | D | ↗ |
| 2025-02-05 | Mahadevia Ankit | Director | S-Sale | D | Common Stock | 13,959 | 0.78 | 10.9K | 745,126 | D | ↗ |
| 2025-02-05 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 24,920 | 0.78 | 19.4K | 741,439 | D | ↗ |
| 2025-02-03 | Shukla Sath | Officer | A-Award | A | Common Stock | 751,407 | 0.00 | — | 1,892,216 | D | ↗ |
| 2025-02-03 | Rajavelu Esther | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 745,409 | D | ↗ |
| 2025-02-03 | Keutzer Timothy | Officer | A-Award | A | Common Stock | 266,139 | 0.00 | — | 797,976 | D | ↗ |
| 2024-11-08 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 17,245 | 1.30 | 22.4K | 379,270 | D | ↗ |
| 2024-11-07 | Rajavelu Esther | Officer | S-Sale | D | Common Stock | 23,351 | 1.31 | 30.6K | 396,515 | D | ↗ |
| 2024-08-27 | Shukla Sath | Officer | S-Sale | D | Common Stock | 2,757 | 1.35 | 3.7K | 1,140,809 | — | ↗ |
| 2024-08-27 | Mahadevia Ankit | Director | S-Sale | D | Common Stock | 5,912 | 1.35 | 8.0K | 759,085 | — | ↗ |
| 2024-08-27 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 2,213 | 1.35 | 3.0K | 531,837 | — | ↗ |
| 2024-08-05 | Shukla Sath | Officer | S-Sale | D | Common Stock | 17,641 | 1.31 | 23.1K | 1,143,566 | — | ↗ |
| 2024-08-02 | Shukla Sath | Officer | S-Sale | D | Common Stock | 14,800 | 1.32 | 19.5K | 1,161,207 | — | ↗ |
| 2024-05-29 | VINK PATRICK V.J.J. | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | Tregoning Kathleen | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | THOMAS FRANK E | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | Smith Cynthia | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | Pottage John C Jr | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | Mahadevia Ankit | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 764,997 | — | ↗ |
| 2024-05-29 | Jackson Scott Thomas | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 55,000 | — | ↗ |
| 2024-05-29 | Deshpande Milind | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 71,454 | — | ↗ |
| 2024-02-05 | Shukla Sath | Director / Officer | S-Sale | D | Common Stock | 45,093 | 1.45 | 65.4K | 1,176,007 | — | ↗ |
| 2024-02-02 | Shukla Sath | Director / Officer | S-Sale | D | Common Stock | 30,901 | 1.37 | 42.3K | 1,221,100 | — | ↗ |
| 2024-02-02 | Mahadevia Ankit | Director | S-Sale | D | Common Stock | 63,795 | 1.37 | 87.4K | 744,997 | — | ↗ |
| 2024-02-02 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 30,971 | 1.36 | 42.1K | 534,050 | — | ↗ |
| 2024-02-02 | JOSEPH TAMARA L | Officer | S-Sale | D | Common Stock | 30,906 | 1.37 | 42.3K | 531,615 | — | ↗ |
| 2024-02-02 | HAMED KAMAL | Officer | S-Sale | D | Common Stock | 28,075 | 1.37 | 38.5K | 788,117 | — | ↗ |
| 2024-02-01 | Shukla Sath | Director / Officer | A-Award | A | Common Stock | 679,501 | 0.00 | — | 1,252,001 | — | ↗ |
| 2024-02-01 | Rajavelu Esther | Officer | A-Award | A | Common Stock | 119,866 | 0.00 | — | 419,866 | — | ↗ |
| 2024-02-01 | Keutzer Timothy | Officer | A-Award | A | Common Stock | 239,731 | 0.00 | — | 565,021 | — | ↗ |
| 2024-02-01 | JOSEPH TAMARA L | Officer | A-Award | A | Common Stock | 239,731 | 0.00 | — | 562,521 | — | ↗ |
| 2024-02-01 | HAMED KAMAL | Officer | A-Award | A | Common Stock | 239,731 | 0.00 | — | 816,192 | — | ↗ |
| 2024-01-02 | Tregoning Kathleen | Director | A-Award | A | Stock Option (Right to Buy) | 35,604 | 1.52 | 54.1K | 35,604 | — | ↗ |
| 2023-11-13 | Rajavelu Esther | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2023-11-06 | Rajavelu Esther | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-05 | VINK PATRICK V.J.J. | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | Tregoning Kathleen | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | THOMAS FRANK E | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | Smith Cynthia | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | Pottage John C Jr | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | Mahadevia Ankit | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 808,792 | — | ↗ |
| 2023-10-05 | Jackson Scott Thomas | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-10-05 | Deshpande Milind | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 51,454 | — | ↗ |
| 2023-09-13 | HAMED KAMAL | Officer | S-Sale | D | Common Stock | 39,496 | 1.27 | 50.2K | 576,461 | — | ↗ |
| 2023-08-29 | Shukla Sath | Director / Officer | S-Sale | D | Common Stock | 4,163 | 1.30 | 5.4K | 572,500 | — | ↗ |
| 2023-08-28 | Shukla Sath | Director / Officer | S-Sale | D | Common Stock | 1,854 | 1.26 | 2.3K | 576,663 | — | ↗ |
| 2023-08-28 | Mahadevia Ankit | Director | S-Sale | D | Common Stock | 9,040 | 1.26 | 11.4K | 788,792 | — | ↗ |
| 2023-08-28 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 1,854 | 1.26 | 2.3K | 325,290 | — | ↗ |
| 2023-08-28 | JOSEPH TAMARA L | Officer | S-Sale | D | Common Stock | 1,854 | 1.26 | 2.3K | 322,790 | — | ↗ |
| 2023-08-01 | Shukla Sath | Director / Officer | A-Award | A | Common Stock | 266,000 | 0.00 | — | 578,517 | — | ↗ |
| 2023-07-15 | DiPalma Stephen J. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-12 | HAMED KAMAL | Officer | A-Award | A | Common Stock | 140,000 | 0.00 | — | 615,957 | — | ↗ |
| 2023-02-03 | Mahadevia Ankit | Director / Officer | S-Sale | D | Common Stock | 12,286 | 1.81 | 22.2K | 797,832 | — | ↗ |
| 2023-02-02 | Shukla Sath | Officer | S-Sale | D | Common Stock | 9,504 | 1.83 | 17.4K | 312,517 | — | ↗ |
| 2023-02-02 | Keutzer Timothy | Officer | S-Sale | D | Common Stock | 3,394 | 1.86 | 6.3K | 327,144 | — | ↗ |
| 2023-02-02 | JOSEPH TAMARA L | Officer | S-Sale | D | Common Stock | 3,394 | 1.86 | 6.3K | 324,644 | — | ↗ |
| 2023-02-01 | Shukla Sath | Officer | A-Award | A | Common Stock | 265,957 | 0.00 | — | 322,021 | — | ↗ |
| 2023-02-01 | Mahadevia Ankit | Director / Officer | A-Award | A | Common Stock | 531,914 | 0.00 | — | 810,118 | — | ↗ |
| 2023-02-01 | Keutzer Timothy | Officer | A-Award | A | Common Stock | 265,957 | 0.00 | — | 330,538 | — | ↗ |
| 2023-02-01 | JOSEPH TAMARA L | Officer | A-Award | A | Common Stock | 265,957 | 0.00 | — | 328,038 | — | ↗ |
| 2023-02-01 | HAMED KAMAL | Officer | A-Award | A | Common Stock | 265,957 | 0.00 | — | 475,957 | — | ↗ |
| 2023-01-03 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (Right to Buy) | 15,471 | 1.29 | 20.0K | 15,471 | — | ↗ |
| 2023-01-03 | Tregoning Kathleen | Director | A-Award | A | Stock Option (Right to Buy) | 30,943 | 1.29 | 39.9K | 30,943 | — | ↗ |
| 2022-11-07 | GSK PLC | Director | — | I | Common Stock | 0 | 0.00 | — | 9,190,606 | — | ↗ |
| 2022-09-22 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 1,335,512 | 2.25 | 3.01M | 3,985,719 | — | ↗ |
| 2022-09-15 | Tregoning Kathleen | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-09-15 | Smith Cynthia | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-09-15 | Pottage John C Jr | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-09-15 | Jackson Scott Thomas | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-09-15 | Deshpande Milind | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 31,454 | — | ↗ |
| 2022-08-29 | Shukla Sath | Officer | S-Sale | D | Common Stock | 6,017 | 0.89 | 5.4K | 56,064 | — | ↗ |
| 2022-04-26 | Aquilo Capital, L.P. | Director | P-Purchase | A | Common Stock, $0.001 par value | 39,727 | 5.24 | 208.0K | 5,321,231 | — | ↗ |
| 2022-04-26 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 39,727 | 5.24 | 208.0K | 5,321,231 | — | ↗ |
| 2022-03-30 | Aquilo Capital, L.P. | Director | P-Purchase | A | Common Stock, $0.001 par value | 33,115 | 8.79 | 291.0K | 5,264,619 | — | ↗ |
| 2022-03-30 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 33,115 | 8.79 | 291.0K | 5,264,619 | — | ↗ |
| 2022-03-14 | Aquilo Capital, L.P. | Director | P-Purchase | A | Common Stock, $0.001 par value | 8,006 | 7.63 | 61.1K | 5,231,504 | — | ↗ |
| 2022-03-14 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 8,006 | 7.63 | 61.1K | 5,231,504 | — | ↗ |
| 2022-02-28 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 15,104 | 9.53 | 143.9K | 5,207,796 | — | ↗ |
| 2022-02-18 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 14,828 | 9.24 | 137.0K | 5,162,963 | — | ↗ |
| 2022-02-01 | Shukla Sath | Officer | A-Award | A | Common Stock | 38,014 | 0.00 | — | 62,081 | — | ↗ |
| 2022-02-01 | Melnick David A. | Officer | A-Award | A | Common Stock | 38,014 | 0.00 | — | 62,081 | — | ↗ |
| 2022-02-01 | Mahadevia Ankit | Director / Officer | A-Award | A | Common Stock | 134,168 | 0.00 | — | 278,204 | — | ↗ |
| 2022-02-01 | Larkin Cristina | Officer | A-Award | A | Stock Option (Right to Buy) | 53,190 | 11.18 | 594.7K | 53,190 | — | ↗ |
| 2022-02-01 | Keutzer Timothy | Officer | A-Award | A | Common Stock | 38,014 | 0.00 | — | 64,581 | — | ↗ |
| 2022-02-01 | JOSEPH TAMARA L | Officer | A-Award | A | Common Stock | 38,014 | 0.00 | — | 62,081 | — | ↗ |
| 2022-01-31 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 125,000 | 11.59 | 1.45M | 5,148,135 | — | ↗ |
| 2022-01-24 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 1,599 | 10.89 | 17.4K | 5,023,135 | — | ↗ |
| 2022-01-18 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 48,488 | 12.41 | 602.0K | 5,021,536 | — | ↗ |
| 2022-01-10 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 8,867 | 12.93 | 114.6K | 4,973,048 | — | ↗ |
| 2022-01-05 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (Right to Buy) | 2,214 | 13.19 | 29.2K | 2,214 | — | ↗ |
| 2022-01-05 | Tregoning Kathleen | Director | A-Award | A | Stock Option (Right to Buy) | 4,428 | 13.19 | 58.4K | 4,428 | — | ↗ |
| 2022-01-05 | THOMAS FRANK E | Director | A-Award | A | Stock Option (Right to Buy) | 2,214 | 13.19 | 29.2K | 2,214 | — | ↗ |
| 2021-12-31 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 125,000 | 15.75 | 1.97M | 4,964,181 | — | ↗ |
| 2021-12-30 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 50,000 | 15.77 | 788.6K | 4,839,181 | — | ↗ |
| 2021-12-29 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 75,493 | 14.64 | 1.11M | 4,789,181 | — | ↗ |
| 2021-12-27 | Mahadevia Ankit | Director / Officer | M-Exempt | A | Common Stock | 8,000 | 5.90 | 47.2K | 152,036 | — | ↗ |
| 2021-11-11 | Tregoning Kathleen | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 16.91 | 253.7K | 15,000 | — | ↗ |
| 2021-10-29 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 150,000 | 17.53 | 2.63M | 4,713,688 | — | ↗ |
| 2021-10-11 | Tregoning Kathleen | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-30 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 134,543 | 18.65 | 2.51M | 4,563,688 | — | ↗ |
| 2021-09-14 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 2,156 | 18.49 | 39.9K | 4,429,145 | — | ↗ |
| 2021-09-13 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 44,210 | 18.56 | 820.7K | 4,426,989 | — | ↗ |
| 2021-09-09 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 24,749 | 18.50 | 457.8K | 4,382,779 | — | ↗ |
| 2021-08-31 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 48,645 | 18.93 | 920.7K | 4,358,030 | — | ↗ |
| 2021-08-30 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 44,042 | 17.87 | 786.9K | 4,309,385 | — | ↗ |
| 2021-08-27 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 13,957 | 16.88 | 235.5K | 4,265,343 | — | ↗ |
| 2021-08-26 | Shukla Sath | Officer | A-Award | A | Common Stock | 24,067 | 0.00 | — | 24,067 | — | ↗ |
| 2021-08-26 | Melnick David A. | Officer | A-Award | A | Common Stock | 24,067 | 0.00 | — | 24,067 | — | ↗ |
| 2021-08-26 | Mahadevia Ankit | Director / Officer | A-Award | A | Common Stock | 78,219 | 0.00 | — | 144,036 | — | ↗ |
| 2021-08-26 | Larkin Cristina | Officer | A-Award | A | Common Stock | 24,067 | 0.00 | — | 25,567 | — | ↗ |
| 2021-08-26 | Keutzer Timothy | Officer | A-Award | A | Common Stock | 24,067 | 0.00 | — | 26,567 | — | ↗ |
| 2021-08-26 | JOSEPH TAMARA L | Officer | A-Award | A | Common Stock | 24,067 | 0.00 | — | 24,067 | — | ↗ |
| 2021-08-26 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 22,982 | 16.55 | 380.3K | 4,251,386 | — | ↗ |
| 2021-08-24 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 40,170 | 16.28 | 653.8K | 4,228,404 | — | ↗ |
| 2021-08-23 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 137,835 | 16.33 | 2.25M | 4,188,234 | — | ↗ |
| 2021-08-20 | Aquilo Capital Management, LLC | 10% Owner | P-Purchase | A | Common Stock, $0.001 par value | 221,190 | 14.86 | 3.29M | 4,050,399 | — | ↗ |
| 2021-08-17 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | Smith Cynthia | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | Pottage John C Jr | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | Jackson Scott Thomas | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | FORMELA JEAN FRANCOIS | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-08-17 | Deshpande Milind | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.69 | 102.7K | 7,500 | — | ↗ |
| 2021-02-08 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 Par Value | 3,000 | 21.74 | 65.2K | 3,829,209 | — | ↗ |
| 2021-02-04 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 Par Value | 34,144 | 18.99 | 648.3K | 3,832,209 | — | ↗ |
| 2021-02-03 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 Par Value | 29,354 | 18.98 | 557.1K | 3,866,353 | — | ↗ |
| 2021-02-02 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 Par Value | 22,841 | 18.99 | 433.8K | 3,895,707 | — | ↗ |
| 2021-02-01 | Melnick David A. | Officer | A-Award | A | Stock Option (Right to Buy) | 57,432 | 19.18 | 1.10M | 57,432 | — | ↗ |
| 2021-02-01 | Mahadevia Ankit | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 179,319 | 19.18 | 3.44M | 179,319 | — | ↗ |
| 2021-02-01 | Larkin Cristina | Officer | A-Award | A | Stock Option (Right to Buy) | 57,432 | 19.18 | 1.10M | 57,432 | — | ↗ |
| 2021-02-01 | Keutzer Timothy | Officer | A-Award | A | Stock Option (Right to Buy) | 57,432 | 19.18 | 1.10M | 57,432 | — | ↗ |
| 2021-02-01 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 Par Value | 13,661 | 19.24 | 262.9K | 3,918,548 | — | ↗ |
| 2021-01-04 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (right to buy) | 1,314 | 17.93 | 23.6K | 1,314 | — | ↗ |
| 2021-01-04 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 1,314 | 17.93 | 23.6K | 1,314 | — | ↗ |
| 2021-01-04 | Smith Cynthia | Director | A-Award | A | Stock Option (right to buy) | 2,629 | 17.93 | 47.1K | 2,629 | — | ↗ |
| 2021-01-04 | Shukla Sath | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-04 | Deshpande Milind | Director | A-Award | A | Stock Option (right to buy) | 2,629 | 17.93 | 47.1K | 2,629 | — | ↗ |
| 2020-12-17 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 250,000 | 18.81 | 4.70M | 3,932,209 | — | ↗ |
| 2020-12-16 | Larkin Cristina | Officer | M-Exempt | A | Common Stock | 12,000 | 5.90 | 70.8K | 13,500 | — | ↗ |
| 2020-12-16 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 14,933 | 18.62 | 278.0K | 4,182,209 | — | ↗ |
| 2020-12-02 | JOSEPH TAMARA L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-09 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 125,900 | 13.77 | 1.73M | 4,197,142 | — | ↗ |
| 2020-11-06 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 5,000 | 13.77 | 68.9K | 4,323,042 | — | ↗ |
| 2020-11-05 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 96,600 | 13.98 | 1.35M | 4,328,042 | — | ↗ |
| 2020-11-04 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,370 | 5.90 | 43.5K | 494,809 | — | ↗ |
| 2020-11-04 | Aquilo Capital Management, LLC | 10% Owner | S-Sale | D | Common Stock, $0.001 par value | 72,500 | 14.26 | 1.03M | 4,424,642 | — | ↗ |
| 2020-11-03 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,137 | 5.90 | 12.6K | 502,179 | — | ↗ |
| 2020-10-27 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | Smith Cynthia | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | Pottage John C Jr | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | Jackson Scott Thomas | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | FORMELA JEAN FRANCOIS | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-27 | Deshpande Milind | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 13.52 | 101.4K | 7,500 | — | ↗ |
| 2020-10-23 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 20 | 5.90 | 118.00 | 504,316 | — | ↗ |
| 2020-10-14 | Mahadevia Ankit | Director / Officer | M-Exempt | A | Common Stock | 105 | 5.90 | 619.50 | 65,922 | — | ↗ |
| 2020-10-13 | Mahadevia Ankit | Director / Officer | S-Sale | D | Common Stock | 14,367 | 14.28 | 205.2K | 65,817 | — | ↗ |
| 2020-09-11 | Aquilo Capital Management, LLC | 10% Owner | — | I | Common Stock, $0.001 Par Value | 0 | 0.00 | — | 4,497,142 | — | ↗ |
| 2020-09-08 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 774 | 5.90 | 4.6K | 518,808 | — | ↗ |
| 2020-07-09 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,293 | 5.90 | 13.5K | 519,582 | — | ↗ |
| 2020-07-07 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 754 | 5.90 | 4.4K | 521,875 | — | ↗ |
| 2020-06-25 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,642 | 5.90 | 15.6K | 522,629 | — | ↗ |
| 2020-06-24 | Mahadevia Ankit | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,880 | 5.90 | 22.9K | 525,271 | — | ↗ |
| 2020-06-23 | Mahadevia Ankit | Director / Officer | M-Exempt | A | Common Stock | 8,045 | 5.90 | 47.5K | 73,862 | — | ↗ |
| 2020-06-23 | Jackson Scott Thomas | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 13.94 | 209.1K | 15,000 | — | ↗ |
| 2020-06-22 | Mahadevia Ankit | Director / Officer | M-Exempt | A | Common Stock | 2,613 | 5.90 | 15.4K | 68,430 | — | ↗ |
| 2020-04-16 | Jackson Scott Thomas | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-02-03 | Melnick David A. | Officer | A-Award | A | Stock Option (Right to Buy) | 55,000 | 9.34 | 513.7K | 55,000 | — | ↗ |
| 2020-02-03 | Mahadevia Ankit | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 180,000 | 9.34 | 1.68M | 180,000 | — | ↗ |
| 2020-02-03 | Larkin Cristina | Officer | A-Award | A | Stock Option (Right to Buy) | 55,000 | 9.34 | 513.7K | 55,000 | — | ↗ |
| 2020-02-03 | Keutzer Timothy | Officer | A-Award | A | Stock Option (Right to Buy) | 55,000 | 9.34 | 513.7K | 55,000 | — | ↗ |
| 2020-01-02 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (right to buy) | 5,408 | 9.87 | 53.4K | 5,408 | — | ↗ |
| 2020-01-02 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 2,704 | 9.87 | 26.7K | 2,704 | — | ↗ |
| 2020-01-02 | FORMELA JEAN FRANCOIS | Director | A-Award | A | Stock Option (right to buy) | 5,408 | 9.87 | 53.4K | 5,408 | — | ↗ |
| 2020-01-02 | Deshpande Milind | Director | A-Award | A | Stock Option (right to buy) | 5,408 | 9.87 | 53.4K | 5,408 | — | ↗ |
| 2020-01-01 | Keutzer Timothy | Officer | — | D | Stock Option (Right to Buy) | 25,000 | 6.26 | 156.5K | 0 | — | ↗ |
| 2019-11-08 | DiPalma Stephen J. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-05 | VINK PATRICK V.J.J. | Director | A-Award | A | Stock Option (right to buy) | 6,073 | 10.67 | 64.8K | 6,073 | — | ↗ |
| 2019-06-05 | THOMAS FRANK E | Director | A-Award | A | Stock Option (right to buy) | 6,073 | 10.67 | 64.8K | 6,073 | — | ↗ |
| 2019-06-05 | Smith Cynthia | Director | A-Award | A | Stock Option (right to buy) | 6,073 | 10.67 | 64.8K | 6,073 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-750.00
Shares Outstanding
57.89M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Esther Rajavelu President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer | 577.2K | 687.5K | 413.7K | — | 372.0K | 11.1K | 2.06M | 20.07% | ↗ |
| 2 | 2025 | Satyavrat Shukla Former President and Chief Executive Officer | 244.2K | 452.8K | 603.4K | — | 307.9K | 416.9K | 2.03M | 29.79% | ↗ |
| 3 | 2025 | Tim Keutzer Chief Operating Officer | 484.6K | 498.8K | 213.7K | — | 232.6K | 11.1K | 1.44M | 14.83% | ↗ |
| 4 | 2024 | Satyavrat Shukla Former President and Chief Executive Officer | 603.8K | — | 1.07M | — | 271.7K | 11.0K | 1.95M | 54.62% | ↗ |
| 5 | 2024 | Satyavrat Shukla Former President and Chief Executive Officer | 603.8K | — | 1.07M | — | 271.7K | 11.0K | 1.95M | 54.62% | ↗ |
| 6 | 2024 | Tim Keutzer Chief Operating Officer | 475.1K | — | 376.4K | — | 171.0K | 11.0K | 1.03M | 36.42% | ↗ |
| 7 | 2024 | Tim Keutzer Chief Operating Officer | 475.1K | — | 376.4K | — | 171.0K | 11.0K | 1.03M | 36.42% | ↗ |
| 8 | 2024 | Esther Rajavelu Interim President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer | 483.3K | — | 188.2K | — | 174.0K | 11.0K | 856.5K | 21.97% | ↗ |
| 9 | 2024 | Esther Rajavelu President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer | 483.3K | — | 188.2K | — | 174.0K | 11.0K | 856.5K | 21.97% | ↗ |
| 10 | 2023 | Ankit Mahadevia, M.D. Former President and Chief Executive Officer | 379.2K | 508.0K | 1,000.0K | — | — | 498.7K | 2.39M | 41.91% | ↗ |
| 11 | 2023 | Satyavrat Shukla Former President and Chief Executive Officer | 524.4K | 336.0K | 904.3K | — | 249.5K | 10.5K | 2.02M | 44.67% | ↗ |
| 12 | 2023 | Satyavrat Shukla President and Chief Executive Officer | 524.4K | 336.0K | 904.3K | — | 249.5K | 10.5K | 2.02M | 44.67% | ↗ |
| 13 | 2023 | Tamara Joseph Former Chief Legal Officer | 458.3K | 315.0K | 500.0K | — | 174.4K | 7.5K | 1.46M | 34.36% | ↗ |
| 14 | 2023 | Timothy Keutzer Chief Operating Officer | 456.2K | 297.5K | 500.0K | — | 174.4K | 10.5K | 1.44M | 34.76% | ↗ |
| 15 | 2023 | Tim Keutzer Chief Operating Officer | 456.2K | 297.5K | 500.0K | — | 174.4K | 10.5K | 1.44M | 34.76% | ↗ |
| 16 | 2023 | Esther Rajavelu Interim President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer | 73.8K | 50.0K | 333.0K | — | — | 1.3K | 458.1K | 72.70% | ↗ |
| 17 | 2022 | Ankit Mahadevia, M.D. Former President and Chief Executive Officer | 633.8K | 254.0K | 1.50M | 1.50M | 342.9K | 9.7K | 4.24M | 70.74% | ↗ |
| 18 | 2022 | Satyavrat Shukla President and Chief Executive Officer | 478.3K | 168.0K | 425.0K | 424.8K | 172.8K | 4.1K | 1.67M | 50.79% | ↗ |
| 19 | 2022 | Satyavrat Shukla President and Chief Executive Officer and Former Chief Financial Officer and Treasurer | 478.3K | 168.0K | 425.0K | 424.8K | 172.8K | 4.1K | 1.67M | 50.79% | ↗ |
| 20 | 2022 | Tamara Joseph Chief Legal Officer | 448.7K | 157.5K | 425.0K | 424.8K | 162.0K | 7.3K | 1.63M | 52.28% | ↗ |
| 21 | 2022 | Tamara Joseph Former Chief Legal Officer | 448.7K | 157.5K | 425.0K | 424.8K | 162.0K | 7.3K | 1.63M | 52.28% | ↗ |
| 22 | 2022 | Timothy Keutzer Chief Operating Officer | 423.8K | 148.8K | 425.0K | 424.8K | 153.0K | 9.7K | 1.59M | 53.61% | ↗ |
| 23 | 2021 | Ankit Mahadevia, M.D. Former President and Chief Executive Officer | 590.4K | — | 1.30M | 2.65M | 327.6K | 6.2K | 4.88M | 81.04% | ↗ |
| 24 | 2021 | Ankit Mahadevia, M.D. Chief Executive Officer | 590.4K | — | 1.30M | 2.65M | 327.6K | 6.2K | 4.88M | 81.04% | ↗ |
| 25 | 2021 | Satyavrat Shukla President and Chief Executive Officer and Former Chief Financial Officer and Treasurer | 440.9K | 164.0K | 400.0K | 1.04M | 175.7K | 8.3K | 2.23M | 64.60% | ↗ |
| 26 | 2021 | Satyavrat Shukla Chief Financial Officer | 440.9K | 164.0K | 400.0K | 1.04M | 175.7K | 8.3K | 2.23M | 64.60% | ↗ |
| 27 | 2021 | Cristina Larkin Former Chief Operating Officer | 460.4K | — | 400.0K | 849.0K | 185.1K | 9.4K | 1.90M | 65.60% | ↗ |
| 28 | 2021 | Tamara Joseph Chief Legal Officer | 410.0K | — | 400.0K | — | 164.1K | 6.0K | 980.1K | 40.81% | ↗ |
| 29 | 2020 | Ankit Mahadevia, M.D. Chief Executive Officer | 536.7K | — | — | 1.15M | 424.0K | 6.1K | 2.12M | 54.41% | ↗ |
| 30 | 2020 | David Melnick, M.D. Chief Medical Officer | 411.5K | — | — | 352.6K | 229.5K | 6.3K | 999.9K | 35.26% | ↗ |
| 31 | 2020 | Christina Larkin Chief Operating Officer | 404.1K | — | — | 352.6K | 226.0K | 9.3K | 992.0K | 35.55% | ↗ |
| 32 | 2020 | Cristina Larkin Former Chief Operating Officer | 404.1K | — | — | 352.6K | 226.0K | 9.3K | 992.0K | 35.55% | ↗ |
| 33 | 2020 | Satyavrat Shukla Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 34 | 2019 | Ankit Mahadevia, M.D. Chief Executive Officer | 497.1K | — | 285.0K | 752.8K | 250.0K | 4.5K | 1.79M | 58.00% | ↗ |
| 35 | 2019 | Christina Larkin Chief Operating Officer | 394.2K | — | 118.5K | 271.8K | 158.0K | 5.5K | 948.0K | 41.17% | ↗ |
| 36 | 2019 | David Melnick, M.D. Chief Medical Officer | 389.2K | — | 118.5K | 271.8K | 156.0K | 4.3K | 939.8K | 41.53% | ↗ |
| 37 | 2018 | David Melnick, M.D. Chief Medical Officer | 375.7K | 10.0K | — | 1.08M | 146.3K | 20.2K | 1.63M | 66.21% | ↗ |
| 38 | 2018 | Ankit Mahadevia, M.D. Chief Executive Officer | 465.0K | — | — | — | 255.8K | 574.00 | 721.3K | 0.00% | ↗ |
| 39 | 2018 | Christina Larkin Chief Operating Officer | 385.0K | — | — | — | 148.2K | 574.00 | 533.8K | 0.00% | ↗ |
| 40 | 2018 | Cristina Larkin Chief Operating Officer | 385.0K | — | — | — | 148.2K | 574.00 | 533.8K | 0.00% | ↗ |
| 41 | 2017 | Ankit Mahadevia, M.D. Chief Executive Officer | 389.6K | — | — | 2.68M | 114.0K | 1.1K | 3.18M | 84.15% | ↗ |
| 42 | 2017 | Christina Larkin, Chief Operating Officer | 330.7K | 98.3K | — | 796.8K | — | 734.00 | 1.23M | 64.96% | ↗ |
| 43 | 2017 | Cristina Larkin Chief Operating Officer | 330.7K | — | — | 796.8K | 98.3K | 734.00 | 1.23M | 64.96% | ↗ |
| 44 | 2017 | Joel Sendek, Chief Financial Officer | 236.7K | 67.9K | — | 905.5K | — | 312.00 | 1.21M | 74.81% | ↗ |
| 45 | 2017 | David Melnick, M.D. Chief Medical Officer | — | — | — | — | — | — | — | — | ↗ |
| 46 | 2016 | Ankit Mahadevia, M.D. Chief Executive Officer | 360.5K | 108.2K | — | 345.1K | — | 1.2K | 815.0K | 42.35% | ↗ |
| 47 | 2016 | Christina Larkin, Chief Operating Officer | 234.4K | 69.2K | — | 105.1K | — | 526.00 | 409.4K | 25.69% | ↗ |
| 48 | 2016 | Joel Sendek, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Esther Rajavelu | CEO, President, CFO, Chief Business Officer, Treasurer & Director | 2M | female |
| Timothy Keutzer | Chief Operating Officer | 1M | male |
| David Hong | Senior Vice President of Clinical Development | — | — |
| John Raymond | Senior Vice President of Finance & Business Operations | — | male |
| Sheila Finan | Senior VP & Controller | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SPRO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
